Homocysteine-induced endothelin-1 release is dependent on hyperglycaemia and reactive oxygen species production in bovine aortic endothelial cells

Journal of Vascular Research

Volumn 43, Issue 2, 2006, Pages 175-183

  Sethi, Amarjit S ^a,b   Lees, Delphine M ^a   Douthwaite, Julie A ^a   Dawnay, Anne B ^a   Corder, Roger ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b EALING HOSPITAL   (United Kingdom)

Author keywords

Endothelial cells; Endothelin 1; Homocysteine; Hyperglycaemia; Reactive oxygen species

Indexed keywords

ACETONE; CARBONYL CYANIDE CHLOROPHENYLHYDRAZONE; ENDOTHELIN 1; HOMOCYSTEINE; REACTIVE OXYGEN METABOLITE; THREONYLTRIFLUOROACETONE; UNCLASSIFIED DRUG;

ANIMAL CELL; AORTA; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; HYPERGLYCEMIA; INCUBATION TIME; MITOCHONDRION; NONHUMAN; OXIDATION; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL;

ANIMALS; AORTA; CARBONYL CYANIDE M-CHLOROPHENYL HYDRAZONE; CATTLE; CELLS, CULTURED; ELECTRON TRANSPORT COMPLEX II; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; GLUCOSE; GLUTATHIONE; HOMOCYSTEINE; HYPERGLYCEMIA; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; THENOYLTRIFLUOROACETONE; THROMBOPLASTIN; UNCOUPLING AGENTS;

EID: 32644471897     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000090947     Document Type: Article

References (43)

1. Welch GN, Loscalzo J: Homocysteine and atherothrombosis. N Engl J Med 1998;338:1042-1050.
2. Silverman MD, Tumuluri RJ, Davis M, Lopez G, Rosenbaum JT, Lelkes PI: Homocysteine upregulates vascular cell adhesion molecule-1 in cultured human aortic endothelial cells and enhances monocyte adhesion. Arterioscler Thromb Vasc Biol 2002;22:587-592.
3. Poddar R, Sivasubramanian N, DiBello PM, Robinson K, Jacobsen DW: Homocysteine induces expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human aortic endothelial cells: implications for vascular disease. Circulation 2001;103:2717-2723.
4. Lang D, Kredan MD, Moat SJ, Hussain SA, Powell CA, Bellamy MF, Powers HJ, Lewis MJ: Homocysteine-induced inhibition of endothelium-dependent relaxation in rabbit aorta: role for superoxide anions. Arterioscler Thromb Vasc Biol 2000;20:422-427.
5. Bennett MR: Reactive oxygen species and death: oxidative DNA damage in atherosclerosis. Circ Res 2001;88:648-650.
6. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, Brownlee M: Normalising mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000;404:787-790.
7. Audelin MC, Genest J Jr: Homocysteine and cardiovascular disease in diabetes mellitus. Atherosclerosis 2001;159:497-511.
8. Hoogeveen EK, Kostense PJ, Jacobs C, Dekker JM, Nijpels G, Heine RJ, Bouter LM, Stehouwer CD: Hyperhomocysteinaemia increases risk of death, especially in type 2 diabetes: 5-year follow-up of the Hoorn study. Circulation 2000;101:1506-1511.
9. Haynes WG, Webb DJ: Endothelin as a regulator of cardiovascular function in health and disease. J Hypertens 1998;16:1081-1098.
10. Jones GT, van Rij AM, Soloman C, Thomson IA, Packer SGK: Endothelin-1 is increased overlying atherosclerotic plaques in human arteries. Atherosclerosis 1996;124:25-35.
11. Lerman A, Edwards BS, Hallett JW, Heublein DM, Sandberg SM, Burnett JC Jr: Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med 1991;325:997-1001.
12. Kinlay S, Behrendt D, Wainstein M, Beltrame J, Fang JC, Creager MA, Selwyn AP, Ganz P: Role of endothelin-1 in the active constriction of human atherosclerotic coronary arteries. Circulation 2001;104:1114-1118.
13. Best PJ, McKenna CJ, Hasdai D, Holmes DR Jr, Lerman A: Chronic endothelin receptor antagonism preserves coronary endothelial function in experimental hypercholesterolemia. Circulation 1999;99:1747-1752.
14. Corder R, Barker S: The expression of endothelin-1 and endothelin-converting enzyme-1 (ECE-1 ) are independently regulated in bovine aortic endothelial cells. J Cardiovasc Pharmacol 1999;33:671-677.
15. Corder R: Peptide Research Protocols: Endothelin; in Maguire JJ, Davenport AJ (eds): Methods in Molecular Biology. Totowa, Humana Press, 2002, vol 206, pp 147-164.
16. Fryer RH, Wilson BD, Gubler DB, Fitzgerald LA, Rodgers GM: Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells. Arterioscler Thromb 1993;13:1327-1333.
17. Khajuria A, Houston DS: Induction of monocyte tissue factor expression by homocysteine: a possible mechanism for thrombosis. Blood 2000;96:966-972.
18. Butenas S, Ribarik M, Mann KG: Synthetic substrates for human factor VIIa and factor VIIa-tissue factor. Biochemistry 1993;32:6531-6538.
19. Douthwaite JA, Lees DM, Corder R: A role for increased mRNA stability in the induction of endothelin-1 synthesis by lipopolysaccharide. Biochem Pharmacol 2003;66:589-594.
20. Cotgreave IA, Moldéus P: Methodologies for the application of monobromobimane to the simultaneous analysis of soluble and protein thiol components of biological systems. J Biochem Biophys Methods 1986;13:231-249.
21. Hernanz A, Fernández-Vivancos A, Montiel C, Vazquez JJ, Arnalich F: Changes in the intracellular homocysteine and glutathione content associated with ageing. Life Sci 2000;67:1317-1324.
22. Upchurch GR Jr, Welch GN, Fabian AJ, Freedman JE, Johnson JL, Keaney JF Jr, Loscalzo J: Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. J Biol Chem 1997;272:17012-17017.
23. Nygard O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE: Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 1997;337:523-527.
24. Drunat S, Moatti N, Paul JL, Cogny A, Benoit MO, Demuth K: Homocysteine-induced decrease in endothelin-1 production is initiated at the extracellular level and involves oxidative products. Eur J Biochem 2001;268:5287-5294.
25. Demuth K, Atger V, Borderie D, Benoit MO, Lotersztajn S, Moatti N: Homocysteine decreases endothelin-1 production by cultured human endothelial cells. Eur J Biochem 1999;263:367-376.
26. Seligman BG, Biolo A, Polanczyk CA, Gross JL, Clausell N: Increased plasma levels of endothelin 1 and von Willebrand factor in patients with type 2 diabetes and dyslipidemia. Diabetes Care 2000;23:1395-1400.
27. Ak G, Buyukberber S, Sevine A, Turk HM, Ates M, Sari R, Savli H, Cigli A: The relation between plasma endothelin-1 levels and metabolic control, risk factors, treatment modalities, and diabetic microangiopathy in patients with type 2 diabetes mellitus. J Diabetes Complications 2001;15:150-157.
28. Quehenberger P, Bierhaus A, Fasching P, Muellner C, Klevesath M, Hong M, Stier G, Sattler M, Schleicher E, Speiser W, Nawroth PP: Endothelin 1 transcription is controlled by nuclear factor-κB in AGE-stimulated cultured endothelial cells. Diabetes 2000;49:1561-1570.
29. Chen HC, Guh JH, Shin SJ, Tsai JH, Lai YH: Reactive oxygen species enhances endothelin-1 production of diabetic rat glomeruli in vitro and in vivo. J Lab Clin Med 2000;135:309-315.
30. Kahler J, Mendel S, Weckmuller J, Orzechowski HD, Mittmann C, Koster R, Paul M, Meinertz T, Munzel T: Oxidative stress increases synthesis of big endothelin-1 by activation of the endothelin-1 promoter. J Mol Cell Cardiol 2000;32:1429-1437.
31. Fernández N, García-Villalón AL, Monge L, Gómez B, Diéguez G: Coronary vascular effects of endothelin-1 during arterial hypotension. J Cardiovasc Pharmacol 1995;26:S214-S215.
32. Ceriello A: Impaired glucose tolerance and cardiovascular disease: the possible role of postprandial hyperglycaemia. Am Heart J 2004;147:803-807.
33. Tsai WC, Li YH, Lin CC, Chao TH, Chen JH: Effects of oxidative stress on endothelial function after a high-fat meal. Clin Sci 2004;106:315-319.
34. Zhang X, Li H, Jin H, Ebin Z, Brodsky S, Goligorsky MS: Effects of homocysteine on endothelial nitric oxide production. Am J Physiol Renal Physiol 2000;279:F671-F678.
35. Heydrick SJ, Weiss N, Thomas SR, Cap AP, Pimentel DR, Loscalzo J, Keaney JF Jr: L-Homocysteine and L-homocystine stereospecifically induce endothelial nitric oxide synthase-dependent lipid peroxidation in endothelial cells. Free Radic Biol Med 2004;36:632-640.
36. Topal G, Brunet A, Millanvoye E, Boucher JL, Rendu F, Devynck MA, David-Dufilho M: Homocysteine induces oxidative stress by uncoupling of NO synthase activity through reduction of tetrahydrobiopterin. Free Radic Biol Med 2004;36:1532-1541.
37. Eberhardt RT, Forgione MA, Cap A, Leopold JA, Rudd MA, Trolliet M, Heydrick S, Stark R, Klings ES, Moldovan NI, Yaghoubi M, Goldschmidt-Clermont PJ, Farber HW, Cohen R, Loscalzo J: Endothelial dysfunction in a murine model of mild hyperhomocyst(e)inemia. J Clin Invest 2000;106:483-491.
38. Kaehler J, Sill B, Koester R, Mittmann C, Orzechowski HD, Muenzel T, Meinertz T: Endothelin-1 mRNA and protein in vascular wall cells is increased by reactive oxygen species. Clin Sci (Lond) 2002;103:176S-178S.
39. Starkebaum G, Harlan JM: Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J Clin Invest 1986;77:1370-1376.
40. Austin RC, Sood SK, Dorward AM, Singh G, Shaughnessy SG, Pamidi S, Outinen PA, Weitz JI: Homocysteine-dependent alterations in mitochondrial gene expression, function and structure. J Biol Chem 1998;273:30808-30817.
41. Cai H, Harrison DG: Endothelial dysfunction in cardiovascular diseases. The role of oxidative stress. Circ Res 2000;87:840-844.
42. Mosharov E, Cranford MR, Banerjee R: The quantitatively important relationship between homocysteine metabolism and glutathione synthesis by the transsulfuration pathway and its regulation by redox changes. Biochemistry 2000;39:13005-13011.
43. Chen P, Poddar R, Tipa EV, Dibello PM, Moravec CD, Robinson K, Green R, Kruger WD, Garrow TA, Jacobsen DW: Homocysteine metabolism in cardiovascular cells and tissues: implications for hyperhomocysteinemia and cardiovascular disease. Adv Enzyme Regul 1999;39:93-109.